NANCY FLATEGRAFF
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family
- Where
- SPRINGFIELD, GA
- NPI
- 1346776002
- Received
- $1,415 in 71 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 5 | $94 |
| 2024 | General payment | 20 | $309 |
| 2023 | General payment | 13 | $221 |
| 2022 | General payment | 24 | $452 |
| 2021 | General payment | 9 | $337 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novo Nordisk Inc | 18 | $405 | 2021–2025 |
| ABBVIE INC. | 15 | $217 | 2024–2025 |
| AstraZeneca Pharmaceuticals LP | 4 | $175 | 2021–2023 |
| PFIZER INC. | 5 | $106 | 2023–2025 |
| Amgen Inc. | 6 | $89 | 2022–2025 |
| Novartis Pharmaceuticals Corporation | 4 | $79 | 2021–2023 |
| Lilly USA, LLC | 4 | $72 | 2022–2023 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 | 2022–2023 |
| Abbott Laboratories | 2 | $42 | 2021–2022 |
| VBI Vaccine (Delaware) Inc. | 3 | $40 | 2022 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 | 2022 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 | 2022 |
| IRONSHORE PHARMACEUTICALS INC. | 1 | $18 | 2023 |
| Corium, LLC | 1 | $15 | 2023 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 | 2022 |
| Vanda Pharmaceuticals Inc. | 1 | $14 | 2025 |
| Amarin Pharma, Inc. | 1 | $13 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 71 | $1,415 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-10-22 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | PFIZER INC. | $27 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2025 | |
| 2025-07-28 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-07-09 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2024-12-19 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-06 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-12-03 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-14 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-05 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-22 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-01 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-08-01 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-29 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-18 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-10 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-05-10 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-04-11 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-04-03 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-03 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2024 | |
| 2024-03-14 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-06 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-31 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-01-24 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-05 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-03-30 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-03-28 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2023 | |
| 2023-03-09 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-03-01 | IRONSHORE PHARMACEUTICALS INC. | $18 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2023 | |
| 2023-03-01 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-02-24 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-02-21 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-02-10 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-01-27 | Corium, LLC | $15 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-01-18 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-01-13 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-01-05 | AstraZeneca Pharmaceuticals LP | $12 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2022-12-02 | VBI Vaccine (Delaware) Inc. | $14 | Food and Beverage | Cash or cash equivalent | PreHevbrio Drug, VACCINE | 2022 | |
| 2022-11-30 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-11-18 | IDORSIA PHARMACEUTICALS US INC | $19 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2022 | |
| 2022-11-18 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-11-11 | VBI Vaccine (Delaware) Inc. | $13 | Food and Beverage | Cash or cash equivalent | PreHevbrio Drug, VACCINE | 2022 | |
| 2022-11-09 | AstraZeneca Pharmaceuticals LP | $12 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2022 | |
| 2022-10-28 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-10-26 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-10-25 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2022 | |
| 2022-10-21 | VBI Vaccine (Delaware) Inc. | $13 | Food and Beverage | Cash or cash equivalent | PreHevbrio Drug, VACCINE | 2022 | |
| 2022-10-14 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2022 | |
| 2022-10-13 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2022 | |
| 2022-10-13 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-10-06 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-09-19 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-08-30 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2022 | |
| 2022-08-25 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-08-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-08-19 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-07-12 | Novo Nordisk Inc | $96 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-06-20 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2022 | |
| 2022-05-04 | Paratek Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2022 | |
| 2022-04-26 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2022 | |
| 2022-04-18 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2021-12-14 | AstraZeneca Pharmaceuticals LP | $133 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-10-27 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-10-08 | Abbott Laboratories | $24 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-07-21 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-07-21 | Novo Nordisk Inc | $5 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 | |
| 2021-07-13 | Novo Nordisk Inc | $102 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-06-24 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2021 | |
| 2021-05-11 | Amarin Pharma, Inc. | $13 | Food and Beverage | In-kind items and services | Vascepa Drug, Cardiovascular | 2021 | |
| 2021-04-21 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Springfield, GA, county Effingham County, GA, state Georgia; placed by its city name.
| Measure | Place (city or town) Springfield, GA | County Effingham County, GA | State Georgia |
|---|---|---|---|
| Population B01003 | 2,974 | 69,143 | 10,940,407 |
| Population, 2020 census P1 | 2,703 | 64,769 | 10,711,908 |
| Median age B01002 | 34.4 | 37.0 | 37.6 |
| Under 18 B01001 | 20.7% | 26.4% | 23.2% |
| 65 and over B01001 | 12.4% | 12.5% | 15.0% |
| Households B11001 | 1,165 | 24,287 | 4,074,366 |
| Foreign born B05002 | 3.6% | 4.2% | 11.2% |
| Median household income B19013 | $62,957 | $88,438 | $77,353 |
| Median family income B19113 | $97,566 | $99,697 | $93,754 |
| Per capita income B19301 | $32,416 | $38,913 | $40,924 |
| Poverty rate B17001 | 8.4% | 6.8% | 13.4% |
| Unemployment rate B23025 | 2.4% | 5.5% | 5.1% |
| Civilian labor force B23025 | 1,524 | 35,010 | 5,496,061 |
| Mean commute (minutes) B08013 | 25.0 | 32.3 | 28.3 |
| Bachelor's degree or higher B15003 | 18.4% | 27.2% | 34.9% |
| Housing units B25001 | 1,251 | 25,943 | 4,541,835 |
| Owner-occupied B25003 | 70.1% | 78.4% | 65.7% |
| Renters B25003 | 29.9% | 21.6% | 34.3% |
| Median home value B25077 | $196,000 | $276,000 | $303,300 |
| Median gross rent B25064 | $1,105 | $1,147 | $1,393 |
| White, not Hispanic B03002 | 72.6% | 72.9% | 49.1% |
| Black B03002 | 20.2% | 14.4% | 30.7% |
| Hispanic or Latino B03002 | 3.9% | 6.6% | 11.0% |
| Asian B03002 | 0.0% | 1.0% | 4.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Economy now FRED unemployment 3.3% in Sep 2026 (3.4% a year earlier); per capita personal income $65,111 in 2025, up 26% in five years (+1.6% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Springfield, GA.
Comments